SteelPeak Wealth LLC Has $2.94 Million Stock Holdings in Herbalife Ltd $HLF

SteelPeak Wealth LLC decreased its position in Herbalife Ltd (NYSE:HLF) by 20.0% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 200,000 shares of the company’s stock after selling 50,000 shares during the period. SteelPeak Wealth LLC owned about 0.19% of Herbalife worth $2,944,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. AQR Capital Management LLC grew its stake in shares of Herbalife by 236.8% during the 1st quarter. AQR Capital Management LLC now owns 133,245 shares of the company’s stock worth $1,150,000 after acquiring an additional 93,686 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Herbalife by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,964 shares of the company’s stock worth $517,000 after purchasing an additional 2,523 shares in the last quarter. Empowered Funds LLC boosted its holdings in Herbalife by 12.9% during the first quarter. Empowered Funds LLC now owns 30,301 shares of the company’s stock worth $261,000 after purchasing an additional 3,474 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Herbalife by 3.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 210,904 shares of the company’s stock worth $1,820,000 after purchasing an additional 6,747 shares during the last quarter. Finally, Envestnet Asset Management Inc. bought a new position in Herbalife in the second quarter valued at $118,000.

Insider Transactions at Herbalife

In other Herbalife news, COO Troy Hicks sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $12.32, for a total value of $123,200.00. Following the sale, the chief operating officer owned 9,706 shares in the company, valued at $119,577.92. This represents a 50.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Frank Lamberti sold 134,982 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $13.50, for a total value of $1,822,257.00. Following the completion of the sale, the insider owned 36,624 shares in the company, valued at $494,424. This represents a 78.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 191,296 shares of company stock worth $2,551,678. 5.13% of the stock is owned by insiders.

Herbalife Trading Down 2.9%

NYSE:HLF opened at $12.01 on Friday. The stock has a market capitalization of $1.24 billion, a PE ratio of 5.27, a P/E/G ratio of 0.68 and a beta of 0.86. Herbalife Ltd has a 1-year low of $7.56 and a 1-year high of $20.40. The firm has a fifty day simple moving average of $12.37 and a 200 day simple moving average of $14.74.

Herbalife (NYSE:HLF) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.61 by $0.03. The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.30 billion. Herbalife had a net margin of 4.67% and a negative return on equity of 41.47%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.59 earnings per share. On average, equities analysts predict that Herbalife Ltd will post 2.68 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on HLF shares. Mizuho set a $17.00 price target on shares of Herbalife in a research note on Monday, May 4th. Zacks Research downgraded shares of Herbalife from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. Wall Street Zen cut Herbalife from a “strong-buy” rating to a “buy” rating in a report on Saturday. Royal Bank Of Canada lowered their target price on Herbalife from $17.00 to $16.00 and set a “sector perform” rating on the stock in a research report on Tuesday, April 28th. Finally, Weiss Ratings upgraded Herbalife from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, June 15th. Three analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $17.80.

About Herbalife

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.